Frankfurt - Delayed Quote EUR
Ocular Therapeutix, Inc. (0OT.F)
As of 3:57 PM GMT+2. Market Open.
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Total Revenue
61,097.00
58,443.00
51,494.00
43,522.00
17,403.00
--
Cost of Revenue
5,599.00
5,281.00
4,540.00
4,406.00
2,083.00
--
Gross Profit
55,498.00
53,162.00
46,954.00
39,116.00
15,320.00
--
Operating Expense
169,968.00
135,544.00
125,608.00
117,153.00
78,167.00
--
Operating Income
-114,470.00
-82,382.00
-78,654.00
-78,037.00
-62,847.00
--
Net Non Operating Interest Income Expense
-2,196.00
-7,355.00
-6,224.00
-6,638.00
-6,600.00
--
Other Income Expense
-21,695.00
9,001.00
13,840.00
78,122.00
-86,189.00
--
Pretax Income
-138,361.00
-80,736.00
-71,038.00
-6,553.00
-155,636.00
--
Net Income Common Stockholders
-138,361.00
-80,736.00
-71,038.00
-6,553.00
-155,636.00
--
Average Dilution Earnings
--
-6,233.00
-9,245.00
-73,712.00
--
--
Diluted NI Available to Com Stockholders
-144,594.00
-86,969.00
-80,283.00
-80,265.00
-155,636.00
--
Basic EPS
-1.08
-1.01
-0.92
-0.09
-2.56
--
Diluted EPS
-1.09
-1.02
-0.97
-0.98
-2.56
--
Basic Average Shares
115,429.42
79,827.36
76,875.04
76,392.87
60,752.23
--
Diluted Average Shares
121,198.65
85,596.59
82,644.27
82,162.10
60,752.23
--
Total Operating Income as Reported
-114,470.00
-82,382.00
-78,654.00
-78,037.00
-62,847.00
--
Total Expenses
175,567.00
140,825.00
130,148.00
121,559.00
80,250.00
--
Net Income from Continuing & Discontinued Operation
-138,361.00
-80,736.00
-71,038.00
-6,553.00
-155,636.00
--
Normalized Income
-116,666.00
-89,738.00
-84,879.00
-84,674.00
-69,447.00
--
Interest Income
12,629.00
3,983.00
798.00
33.00
168.00
--
Interest Expense
14,825.00
11,338.00
7,022.00
6,671.00
6,768.00
--
Net Interest Income
-2,196.00
-7,355.00
-6,224.00
-6,638.00
-6,600.00
--
EBIT
-123,536.00
-69,398.00
-64,016.00
118.00
-148,868.00
--
EBITDA
-119,812.00
-66,415.00
-61,907.00
2,539.00
-146,095.00
--
Reconciled Cost of Revenue
5,599.00
5,281.00
4,540.00
4,406.00
2,083.00
--
Reconciled Depreciation
3,724.00
2,983.00
2,109.00
2,421.00
2,773.00
--
Net Income from Continuing Operation Net Minority Interest
-138,361.00
-80,736.00
-71,038.00
-6,553.00
-155,636.00
--
Total Unusual Items Excluding Goodwill
-21,695.00
9,002.00
13,841.00
78,121.00
-86,189.00
--
Total Unusual Items
-21,695.00
9,002.00
13,841.00
78,121.00
-86,189.00
--
Normalized EBITDA
-98,117.00
-75,417.00
-75,748.00
-75,582.00
-59,906.00
--
12/31/2019 - 9/29/2014
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade